$12.00
Additional information
| Active substance | Levocetirizine  | 
		
|---|---|
| Water Retention | Negligible  | 
		
| Hepatotoxicity | Low  | 
		
| Lab Test | Not routinely required  | 
		
| Strength | 5mg  | 
		
| Also known as | Levocetirizine dihydrochloride  | 
		
| Blood pressure | Generally does not affect blood pressure significantly  | 
		
| Trade name | Xyzal  | 
		
| Storage conditions | Store at room temperature, away from excess heat and moisture  | 
		
| Chemical name | (R)-2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid  | 
		
| Formula | C21H25ClN2O3  | 
		
| Substance class | Antihistamine  | 
		
| Main action | H1 histamine receptor antagonist  | 
		
| Half-life | 6 to 10 hours  | 
		
| Dosage (medical) | 5 mg once daily  | 
		
| Dosage (sports) | Not applicable  | 
		
| Effects | Relief from allergic symptoms such as sneezing, runny nose, itchy or watery eyes, and hives  | 
		
| Side effects | Drowsiness, fatigue, dry mouth, headaches  | 
		
| Use in sports | No specific use in sports  | 
		
| Manufacturer | Cipla Ltd.  | 
		
| Packing | 10 tabs/blister  | 
		







